30 August 2024 in Journal of Contextual Behavioral Science
10 October 2025 in Substance Use & Misuse
Tobacco use is a significant national health concern that frequently co-occurs with chronic pain. Both pain and use of nicotine/tobacco have been linked to greater sleep impairments (i.e., trouble initiating and maintaining sleep), and there is reason to believe that more severe pain may indirectly contribute to greater nicotine dependence via sleep impairments. Therefore, the goal of this study was to examine indirect associations between pain severity and nicotine dependence via sleep impairment severity among adults who use cigarettes and electronic nicotine delivery systems (ENDS). Data were drawn from Wave 6 (March - November 2021) of the Population Assessment of Tobacco and Health Study (PATH), limited to N = 9,682 (54% male; 22% ages 25-24; 77% White) participants who reported regular cigarette smoking and/or ENDS use. Pain severity and sleep impairment were assessed using single items, and nicotine/tobacco dependence was assessed using the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Results indicated positive indirect associations between pain severity and both tobacco and ENDS dependence via sleep impairment severity. Sleep impairment may play an important role in associations between pain severity and nicotine dependence among adults who use cigarettes or ENDS. These findings and future work may warrant the development of interventions that address sleep dysfunction to support nicotine and tobacco cessation, particularly among adults who experience pain.
7 June 2026 in Journal of Psychoactive Drugs
U.S. military veterans face an elevated suicide risk compared to the general population. Both the use and misuse of tranquilizers (i.e. several classes of medications that treat anxiety and muscle spasms via central nervous system action, including benzodiazepines) have been associated with suicidal thoughts and behaviors among veterans. However, it remains unclear whether risk varies across different patterns of tranquilizer use. Participants included 12,584 U.S. military veterans (13.0% female; 78.1% non-Hispanic White; 49.3% age 65 and older), from the 2015-2019 National Survey on Drug Use and Health (NSDUH). Tranquilizer use without misuse was associated with greater odds of suicidal ideation and planning, relative to nonuse (p's < 0.01). Tranquilizer misuse was associated with greater odds of suicide ideation, planning, and attempts compared to nonuse (p's < 0.01). Relative to use without misuse, tranquilizer misuse was associated with greater odds of suicide ideation, planning, and attempts (p's < 0.01). These results support a graded association between tranquilizer use/misuse and suicidal thoughts and behaviors, suggesting that risk for suicide-related outcomes may increase from no use, to use without misuse, to misuse. Future research should explore the clinical utility of addressing tranquilizer use/misuse as part of targeted suicide prevention strategies among veterans.
11 June 2026 in Rehabilitation Psychology
Women with Chiari malformation (CM), a congenital physical disability associated with significant chronic pain, frequently experience functional difficulties and depression. This study examined whether chronic pain acceptance, defined as the ability to acknowledge unpleasant sensations without attempting to alter or avoid them, mediates the association between functional difficulties and depression symptoms. This study included a baseline and 1-month follow-up assessment of 100 women with CM. At baseline, participants completed the interference subscale of the Brief Pain Inventory, the Instrumental Activities of Daily Living scale, and the Chronic Pain Acceptance Questionnaire; at 1-month follow-up, participants completed the depression subscale of the 21-item version of the Depression, Anxiety, and Stress Scale. Mediation analyses were conducted using maximum likelihood estimation with missing values. Chronic pain acceptance fully mediated the relationship between Instrumental Activities of Daily Living scores and depression symptoms, accounting for 76% of the total effect (b = 0.87, SE = 0.28, p = .002). Chronic pain acceptance partially mediated the relationship between pain interference and depression symptoms, accounting for 29% of the total effect (b = 0.71, SE = 0.30, p = .02). Chronic pain acceptance may be one possible modifiable mechanism linking functional difficulties and pain interference to depression symptoms among women with CM, suggesting that interventions targeting chronic pain acceptance may reduce depression risk in this population. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
29 June 2026 in Nicotine & Tobacco Research
Introduction: Veterans are more likely than non-veterans to report disability and to use tobacco products. Although prior research has linked disability status and related functional difficulties with tobacco use in the general population, research among veterans is limited. Methods: The sample included 10,542 U.S. military veterans who completed the 2020—2023 National Health Interview Survey. Tobacco use was categorized as non-use, single-product use, or poly-tobacco use. Functional difficulties were measured in NHIS using the Washington Group Short Set and categorized as no, some, or significant difficulties. Binary and multinomial logistic regression models adjusted for relevant sociodemographic covariates. Results: Veterans with some functional difficulties had higher odds of cigarette, e-cigarette, and pipe use compared with those reporting no difficulties (AORs 1.35—1.90), whereas veterans with significant functional difficulties had more than twice the odds of such product use. Veterans with some or significant functional difficulties were at higher relative risk of poly-tobacco use (vs. non-use), and significant difficulties were associated with higher relative risk of poly-tobacco use (vs single-product use) relative to those with no difficulties. Compared with veterans reporting some difficulties, those with significant difficulties had higher odds of cigarette (AOR = 1.49) and e-cigarette use (AOR = 1.54), and higher relative risk of poly-tobacco use (vs non-use: RRR = 1.74; vs single-product use: RRR = 1.50). Conclusions: Results indicated a graded association between severity of disability-related functional difficulties and tobacco use patterns among veterans. Future research should develop and test tobacco cessation interventions tailored to veterans with varying levels of disability-related functional difficulties. Implications: The results provide evidence that greater severity of disability-related functional difficulties is associated with higher odds of both single-tobacco and poly-tobacco product use among U.S. military veterans. Veterans with more severe functional limitations may be particularly vulnerable to poly-tobacco use, which may place such veterans at heightened risk for tobacco-related harms. Findings underscore the utility of incorporating assessment of disability-related functional difficulties into tobacco risk screening and developing accessible, tailored cessation interventions for veterans who experience varying levels of functional impairment.
30 September 2024 in Journal of Health Psychology
To examine the levels of patient self-advocacy in a sample of participants with Chiari Malformation (CM) and to explore how they relate to clinical outcomes. As part of a larger clinical trial addressing chronic pain in patients with CM, 111 participants completed the Patient Self Advocacy Scale (PSAS), the Depression, Anxiety, and Stress Scale (DASS-21), and the Brief Pain Inventory (BPI). PSAS scores indicated a moderately high level of patient self-advocacy (Mean = 3.86 SD = 0.50). The PSAS was not related to depression, anxiety, stress, pain intensity, or pain interference. There were no differences in PSAS according to surgical status ( t (61.25) = 0.44, p = 0.66) or use of pain medication ( t (109) = 1.05, p = .29). Participants in a clinical trial for CM have high levels of pre-existing patient self-advocacy. Research is needed to understand how patient self-advocacy contributes to the management of CM and how it could impact research of individuals with understudied conditions. Clinical Trials Registration: NCT05581472